Cargando…
Elevated Mutational Age in Blood of Children Treated for Cancer Contributes to Therapy-Related Myeloid Neoplasms
Childhood cancer survivors are confronted with various chronic health conditions like therapy-related malignancies. However, it is unclear how exposure to chemotherapy contributes to the mutation burden and clonal composition of healthy tissues early in life. Here, we studied mutation accumulation i...
Autores principales: | Bertrums, Eline J.M., Rosendahl Huber, Axel K.M., de Kanter, Jurrian K., Brandsma, Arianne M., van Leeuwen, Anaïs J.C.N., Verheul, Mark, van den Heuvel-Eibrink, Marry M., Oka, Rurika, van Roosmalen, Markus J., de Groot-Kruseman, Hester A., Zwaan, C. Michel, Goemans, Bianca F., van Boxtel, Ruben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613255/ https://www.ncbi.nlm.nih.gov/pubmed/35678530 http://dx.doi.org/10.1158/2159-8290.CD-22-0120 |
Ejemplares similares
-
Antiviral treatment causes a unique mutational signature in cancers of transplantation recipients
por: de Kanter, Jurrian K., et al.
Publicado: (2021) -
MutationalPatterns: the one stop shop for the analysis of mutational processes
por: Manders, Freek, et al.
Publicado: (2022) -
Whole-genome sequencing and mutational analysis of human cord-blood derived stem and progenitor cells
por: Rosendahl Huber, Axel, et al.
Publicado: (2022) -
Mutation Signatures of Pediatric Acute Myeloid Leukemia and Normal Blood Progenitors Associated with Differential Patient Outcomes
por: Brandsma, Arianne M., et al.
Publicado: (2021) -
P1316: ASSESSING GENOMIC SAFETY OF ANTIVIRAL NUCLEOSIDE ANALOGS IN HEMATOPOIETIC STEM CELLS
por: Peci, F., et al.
Publicado: (2022)